chrisvoncsefalvay/vaers-outcomes huggingface dataset:
received Pfizer vaccine through on 2/19/2021.  Pt woke on 2/26/2021 with a bad headache on left side of her head, left side of her neck was sore & there was a lump on her left clavicle.  She went to her PCP's walk-in clinic on 2/26/2021.  Diagnosed with a bright red left ear, swollen lymph nodes on the left side of her neck, clavicle & left arm pit.  She was prescribed Amoxicillin for 10 days.
Slight throat swelling, very sore throat at about 45 minutes after injection.  This lasted about 8 hours.  Severe headache at 4 hours, lasted approximately 36 hours.  Stomach pain, fever, chills, muscle aches at 18 hour mark lasting 48 hours.
Information has been received from a 72 year old male with high blood pressure and no drug reactions or allergies who on 09-MAR-2011 was vaccinated SC with a 0.65 ml dose of ZOSTAVAX (Merck). Concomitant therapy included simvastatin (manufacturer unknown). On 19-APR-2011 the patient developed a rash, which had gone away but was still sensitive around the skin. The patient sought unspecified medical attention. No treatment was given for the event. No lab diagnostics studies were performed. Follow-up information was received from the patient indicating that since 19-APR-2011 he had had itching on his ankles, legs and in-steps of his feet. He went to see a dermatologist. There was no visible rash or skin irritation. The dermatologist said it "was dry skin". The patient reported constant itching and "sensation" of itching. No further information is available.
Diarrhea following rotavirus vaccine, positive reducing substance in stool 12/07/07. Diarrhea x 6 wks - nl growth.
I have noticed an alteration in my taste of peanut butter only. Peanut butter of all brands gives a foul metallic type taste that invades my mouth AND nose like fumes. No other reaction as far as I can tell occurs. No hives no itching no swelling. I was taking no new medications at that time and was not sick. I have never had any issues eating Peanut butter and I am not currently pregnant.
Information has been received from a physician concerning a 15 year old female, who, on an unspecified date, was vaccinated with a dose of Gardasil (Lot # 655165/1425F or 658488/0930U).  Subsequently the patient fainted after administration (also reported as the patient "didn't completely faint, but was close to it").  The patient recovered on an unspecified date without incident after sitting in the office.  She went home without complication.  This is one of 3 reports from the same source.  Additional information has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 60-year-old male patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm and mobility decreased. On an unknown date, the outcome of the pain in arm and mobility decreased were unknown. It was unknown if the reporter considered the pain in arm and mobility decreased to be related to SHINGRIX. Additional details were provided as follows: The health care professional mentioned that himself, had gotten 2 doses of SHINGRIX. He was a 60 years old male who got the first dose of SHINGRIX and said he had a lot of arm pain that he could barely lift his arm. This case has been linked with US2018084276 (case for same patient) and US2018084274, reported by the same reporter.
Patient c/o thick feeling in her throat and it feeling tingly; patient a little shaky; vital signs good-1355 bp was 128/82; 1405 - bp 124/82; respirations 16 and 18; pulse between 80 and 84.  Administered Benadryl 20ml/50mg; patient was talking, laughing and eating chips, stated throat felt better. Her ride came to get her at 1457.
I exp shaking and headache lasted few hours . I went to the doctor on 3/17 had a UTI(which is not normal for me).
Immediate wheal at injection site pt was given Varicella on 7/31/06 in the right arm by Vaccine provider. Immediate wheal was seen at injection site. Pt was given 1 1/2 tsp Benadryl and he stayed at the office for 20 min for observation. Pt was doing fine and he was sent home we will call to check pt.
Deep Vein Thrombosis in both legs; eye was completely black/veins in the back of eye are completely black; eyes started to go very blurry; scared to sleep at night, scared to move/afraid to live life, petrified with this; arm is sore and puffed up; arm is sore and puffed up; A spontaneous report was received from a consumer, concerning a 72-year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and developed deep vein thrombosis (DVT) in both legs/deep vein thrombosis, one clot from groin to mid chest and one behind knee to groin, quite large and very risky, extremely large thrombus, scared to sleep at night, scared to move, afraid to live life, petrified with this/ fear, eyes started to go very blurry/ vision blurred, left eye was completely black and veins in the back of eye are completely black/ eye contusion and arm was sore/ pain in extremity and puffed up/ peripheral swelling.  The patient's medical history included being a cancer survivor twice. No relevant concomitant medications were reported.  On 26 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 014M20A) intramuscularly in left arm for prophylaxis of COVID-19 infection.   On 09 Mar 2021, approximately ten days after receiving vaccine, the patient's eyes started to go very blurry, her left eye was completely black and veins in the back of eye were completely black. On 10 Mar 2021, she had one clot from groin to mid chest and one behind knee to groin, quite large and very risky, extremely large. She was afraid to live her life and  was petrified.  She developed a DVT in both legs and was taken to the emergency room.  She was hospitalized on 10 Mar 2021and had positron emission tomography (PET) scan, doppler, echocardiogram with pictures of face and neck. Her lung was dyed, she had 3 types of dye, had PET scan for brain, chest, blood draws from finger and shots of blood thinner in stomach. She was scared to sleep at night and scared to move. Her arm was sore and puffed up. On 13 Mar 2021, she was discharged from the hospital.  Treatment of the events included Eliquis.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events, deep vein thrombosis, fear, vision blurred, eye contusion, pain in extremity and peripheral swelling were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
improperly stored temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medication and concurrent condition were not provided.     On 06-AUG-2020, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot# S020962, expiration date 07-JUL-2021, dose reported as 1 (unit not provided); strength and route were not provided), and varicella virus vaccine live (oka/merck) (VARIVAX) (lot# S038175, expiration date 26-NOV-2021, dose reported as 1 (unit not provided); strength and route were not provided) both for prophylaxis (product storage error). The temperature excursions included -6 fahrenheit degree to 14 fahrenheit degree (10 fahrenheit degree) for 1 hour and 15 minutes, 15 fahrenheit degree to 46 fahrenheit degree (44.8 fahrenheit degree) for 1 hour and 30 minutes and 47 fahrenheit degree to 77 fahrenheit degree (50 fahrenheit degree) for 2 hours and 30 minutes. There was no previously temperature excursion. There was a data logger involved.
Fever, night sweats, chills from 26 hours after receiving second dosage for approximately 13 hours before fever broke.
Pt recv vax on 10/19/98; on 10/30/98 pt exp red, bruised, warm, swelling (11x11.5cm)
I had no symptoms except a very sore arm the first shot .  After 2nd shot I had Unexplained severe pain in my foot for hours and then it went away the next day. I could not walk as I could not bear any weight on it.   Also with the 2nd shot I had fever, chills, sweats, head ache, body aches, exhaustion  and nauseous for a good 36 hours.  My husband was afraid the pain in the foot was a blood clot and wanted me to go to the hospital but I was honestly just to sick to go to the hospital.  I was too sick to move.  After 36 hours most symptoms disappeared leaving just fatigue for the next 24 hours.
PATIENT WAS GIVEN PFIZER VACCINE, WAITED FOR 15 MINUTES, CAME UP TO THE PHARMACY AND WAS COMPLAINING OF A HEADACHE. PATIENT WAS GIVEN WATER AND WENT TO SIT DOWN. WHEN SHE SAT DOWN HER HEAD TILTED BACK AND HER EYES STARTED ROLLING BACK IN HER HEAD.  SHE WAS THEN TAKEN AWAY IN AN AMBULANCE.
Face swollen too after vaccination; This is a spontaneous report from a contactable consumer or other non hcp.  This consumer (Patients wife) reported for a male patient (Reporters husband) that: A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, dose 1 via an unspecified route of administration, dose 1 administered in Arm Left on 03Apr2021 11:00 AM (Batch/Lot Number: ER8134, expiry date: unknown) as Dose 1 SINGLE for covid-19 immunization. Medical history included heart arrhythmia from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient received Iron, prenatal vitamins, magnesium, probiotics within 2 weeks of vaccination. The patient was not diagnosed with covid-19 before or after vaccination. The patient had not received other vaccines within 4 weeks prior to the COVID vaccine.  On 03Apr2021, patient experienced face swollen too after vaccination (swelling face) Within 30 minutes (including 15minutes of wait after vaccination). The patient had not received any treatment for the event. On an unspecified date outcome of the event was recovered with sequelae.   Follow-up attempts completed. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021407080 same drug/AE, different patient
I received the first dose of my vaccine at 4:20 pm. My left arm was sore at the injection site pretty quickly as I would have expected.  At about 9:30 pm, I noticed that both of my hands were painful and achy  (I assumed the cause was flu-like symptoms from the vaccine). Upon examination of my hands, I noticed that my veins were significantly enlarged and bulging from partway down my forearms through my hands. When I raised my hands in the air, the veins became smaller and the pain subsided. I took 2 advil and went to bed with my hands slightly elevated. When I woke up in the morning, the veins were back to normal.
Loss of hearing in L ear, tinnitus in L ear, Fullness in L ear, Episode of Vertigo resulting in an emergency Room visit.
Headache - 12 hours after injection, 4am 4/1-2am 4/2  swollen glands, ear pain, chills, body aches, fatigue - 24 hours after injection - 3pm 4/1-2am 4/2
Information has been received from a health professional concerning a 4 year old white male, with no medical history and no allergies, who on 11/20/02, at 10:00, was vaccinated with a first SC dose in the left deltoid of varicella virus vaccine live (lot # 643084/0472M). There was no concomitant medication and no illness at the time of vaccination. It was reported that on 10/9/05 the patient's mother called the office regarding a rash that the patient developed on 10/9/05. The mother described the rash as red bumps, initially red and then cloudy white blisters. There were 30 to 60 lesions. The patient was seen by the physician, today, on 10/10/05. The physician confirmed the diagnosis of chicken pox. No treatment was ordered. There were no laboratory or diagnostic tests performed. No product quality complaint was involved. Follow up information indicated that the outcome was unknown. Additional follow up indicated that the office had not heard from the family since the office visit on 10/10/05. Details of the illness and recovery status are unknown. Additional follow up from a health professional indicated that this child is not in their database and she has no additional information on this case. No further information is available.
This case was reported by a healthcare professional describe the occurrence of leg rash in an adult female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). On 30 October 2008  12:00 the subject received a dose of FLULAVAL at 0.5 ml. On 1 November 2008, 48 hours after vaccination with FLULAVAL, the subject experienced leg rash and itching. Rash on ankles was also reported. The subject treated with corticosteroids and antihistamines. At the time of reporting the events were unresolved. The healthcare professional considered the events were possibly related to vaccination with FLULAVAL. The reporter stated that 6 subjects in an employee flu clinic developed a rash on their legs and ankles approximately two days after receiving the FLULAVAL vaccine. The subjects describes the rash as appearing as a heat rash. Two of the subjects were females and were treated by a physician with corticosteroids and antihistamines. Some of the subjects were males, but exact details were not known. The healthcare professional reported additional cases see: A0757694A and A0757715A- A0757717A, A0757719A. Follow-up information was received on 09 December 2008, via healthcare professional who reported she was not sure if the event was related to the vaccine or not. The healthcare professional stated that 01 December 2008 the complaint was resolved. The reporter stated she was told that two females and three males had a rash. As of this report, healthcare professional had not received further information. She did stated that two subject saw their private physicians.
Got shingles rash day after vaccine. Started small with quarter size. Now (6/16=3pm) about 3" across.
As patient was sitting for 15 minute waiting period after receiving Pfizer COVID-19 vaccine, patient lost consciousness. He fell from a sitting position and bumped his lip on a shelf. Patient quickly regained consciousness after less than 1 minute. Helped him sit back into a chair. Patient reiterated he was "okay" but began to lose consciousness again, then woke up after less than 30 seconds. Checked blood pressure with his consent which was 116/64, pulse 64. Medics arrived shortly for additional testing.
This spontaneous report has been received from a registered nurse, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On 21-SEP-2018, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot # N023828 with expiration date reported as 25-JUN-2020 (dose, frequency and route were not provided) for prophylaxis. No adverse effects reported. The vaccine was stored at a temperature of 47 Fahrenheit degree to 77 Fahrenheit degrees with a time frame of 1 hour and 10 minutes and previous temperature excursion of 47 Fahrenheit degree to 77 Fahrenheit degrees for 1 hour and 27 minutes and 47 Fahrenheit degree to 77 Fahrenheit degrees for 1 hour and 5 minutes. Digital Data logger was involved. This is one of eight reports received from the same reporter.; Sender's Comments: US-009507513-1809USA013685: US-009507513-1809USA013686:  US-009507513-1809USA013687: US-009507513-1809USA012930: US-009507513-1809USA013688: US-009507513-1809USA013682: US-009507513-1809USA013683:
Pt recvd vax & 15-30 mins p/inject exp rash; was seen by MD; treated w/Epi sx resolved;
pt recvd vax & had sz-convulsed-became unresponsive paramedics called when pt had sx; pt taken to ER; EEG on 17MAY94;
pt recvd vax; 7aug95 devel large vesicle on arm that crusted w/ several small satellite vesicles around site of the first;
Pt to ER with fever, sob started on 11/19/2001 afternoon. Congestion, headache, left arm swollen and red around injection site. Pt given Prednisone, Lortab and discharged.
This case was reported by a physician via sales rep and described the occurrence of pain in arm in a 66-year-old male patient who received SHINGRIX for prophylaxis. The patient's past medical history included chickenpox (at the age of 2 years) and shingles (mild case at the age of 31 years). Previously administered products included ZOSTAVAX (received in 2012). On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm, shivering and fever. On an unknown date, the outcome of the pain in arm, shivering and fever were unknown. It was unknown if the reporter considered the pain in arm, shivering and fever to be related to SHINGRIX. Additional details were provided as follows: This case was reported by physician for himself. The age at vaccination was not reported but it could be 65 or 66 years. After receiving SHINGRIX, the patient experienced fever of 102 to 103 degree F. The medical science liaison (MSL) did not have any demographic information for the physician. The reporter did not agree to be contacted for follow up information. Lab Comments: Lab test was done on an unknown date.
This is a spontaneous report from a contactable physician. A 59-year-old Anglo female patient received PREVNAR 13, via an unspecified route of administration on 18Jul2016 at single dose for immunization. The reporter was unable to clarify if this was the patient's first dose. The patient's medical history and concomitant medications were not reported. The patient previously received the Pneumococcal 23 in 2014, Lot number: K007824. The patient experienced flu type stuff, redness was 6 centimeters, still experiencing intermittent pain in shoulder, joint pain everywhere where she can't move, still has some weird symptoms going on an unspecified date. The patient also experienced huge swelling at sight of injection in Jul2016. Reporter mentioned the patient's weird symptoms haven't gone away, unable to say was it tied to vaccine or not. Flu type stuff clarified as muscle ache and fatigue. As well as upper respiratory sort of stuff. Patient had reported to reporter on 20Jul2016 she had the reaction of swelling the size of baseball where injection was given. Reporter explained by the time he saw the patient most of the swelling had gone away she had redness. Reporter explained when he saw the patient the sight of injection was not as bulging. Joint pain everywhere where she can't move: reporter explained everything he was checking the patient for was negative. The outcome of the events, still has some weird symptoms going on, intermittent pain in shoulder, were not recovered. The outcome of the other events was unknown.
Tightness in upper chest and throat. Difficulty breathing, not completely blocked just shallow and lead to dizziness
Havrix administered 1 day after expiration; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 72-year-old female patient who received HAV (Havrix) (batch number H4H53, expiry date 30th January 2023) for prophylaxis.   On 31st January 2023, the patient received Havrix. On 31st January 2023, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 31-JAN-2023 Reporter's Comments: Registered nurse reported Havrix was administered 1 day after expiration.  Havrix was administered on 31st January 2023 and expired on 30th January 2023. The reporter consented to follow up. Additional Supportive Information: The patient received Havrix, which was already expired.
pt recv vax 4FEB97 & 11FEB97 pt devel chickenpox w/approx 50 lesions over entire body;the pt transmitted this to her sister who developed a full-blown case of chicken pox (WAES 97030970)
Headache, Sedation, Fever, NauseaVomiting, HEARTBURN, EAR PRESSURE Narrative:
Significant edema and redness occurred in a 5 inch area around vaccine site 8 days following vaccine.
This Non valid spontaneous report was received from a registered nurse and refers to an unspecified number of unspecified patients of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On dates on or after 21-SEP-2017, the patients were vaccinated with improperly stored dose of PEDVAXHIB for prophylaxis, lot# N000238 with expiration date of 25-OCT-2019, lot# N003701 with expiration date of 01-NOV-2019, lot# N008079 with expiration date of 02-DEC-2019, lot# N012920 with expiration date of 07-FEB-2020 (strength, dose, route and frequency were not reported); or with improperly stored dose of RECOMBIVAX HB for prophylaxis, lot# N020613 with expiration date of 05-MAY-2020, lot# N002202 with expiration date of 04-NOV-2019, lot# N011851 with expiration date of 19-DEC-2019; or with improperly stored dose of ROTATEQ orally, for prophylaxis, lot# N000175 with expiration date of 20-SEP-2018, lot# N005618 with expiration date of 04-OCT-2018, lot# N005078 with expiration date of 22-NOV-2018; or with improperly stored dose of VAQTA for prophylaxis, reported lot# M019924 with expiration date of 02-SEP-2018, lot# N008823 with expiration date of 26-MAY-2018. No adverse effects were reported. It was stated that the vaccines underwent a temperature excursion of 32°F (degrees Fahrenheit) to 35°F for 40 minutes; No previous temperature excursion was done. The call was because of a "data logger". This is a non-valid case due to lack of patient identifier. Follow up information was received from the registered nurse 30-APR-2018. The nurse stated the temperature excursion was stable and they had two refrigerators that held the related vaccines. The nurse was not able to provide patients' names or initials, or ages, but was able to provide number of patients, gender information, and vaccination dates. This report referred to a male patient vaccinated with improperly stored ROTATEQ (oral; lot# N005078 with expiration date 22-NOV-2018) on 25-SEP-2017. Upon receipt of follow-up information it was determined that this case is now valid because patient identifier was received. This is one of several reports received form the same reporter(link reports: 1710USA004069, 1805USA001661, 1805USA004617, 1805USA004618, 1805USA004590, 1805USA004591, 1805USA004592, 1805USA004593, 1805USA004674, 1805USA004675, 1805USA004676, 1805USA004677, 1805USA004679, 1805USA004680, 1805USA004681, 1805USA004682, 1805USA004683, 1805USA004967, 1805USA004968, 1805USA004969, 1805USA004970, 1805USA004971, 1805USA004972, 1805USA004973, 1805USA004974, 1805USA004975, 1805USA004976, 1805USA004977, 1805USA004978, 1805USA004979, 1805USA004980, 1805USA004981, 1805USA004982).
Numbness and tingling in bilateral upper extremities, jaw, posterior scalp.  Chest pain/tightness.  Pt seen in local ER and evaluated with Labs, CT imaging, EKG and discharged with non-specific chest pain/parasthesias.